71.53
+0.71(+1.00%)
Currency In USD
| Previous Close | 70.82 |
| Open | 71.01 |
| Day High | 72.18 |
| Day Low | 69.63 |
| 52-Week High | 73.72 |
| 52-Week Low | 52.5 |
| Volume | 465,238 |
| Average Volume | 366,824 |
| Market Cap | 1.54B |
| PE | -68.78 |
| EPS | -1.04 |
| Moving Average 50 Days | 65.92 |
| Moving Average 200 Days | 60.4 |
| Change | 0.71 |
If you invested $1000 in ANI Pharmaceuticals, Inc. (ANIP) 10 years ago, it would be worth $1,369 as of May 09, 2025 at a share price of $71.53. Whereas If you bought $1000 worth of ANI Pharmaceuticals, Inc. (ANIP) shares 5 years ago, it would be worth $2,055.46 as of May 09, 2025 at a share price of $71.53.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
GlobeNewswire Inc.
May 05, 2025 11:00 AM GMT
Demonstrated Dose Dependent Effect in EAU Presented in a podium presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2025 annual meeting PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
GlobeNewswire Inc.
Apr 09, 2025 10:50 AM GMT
PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2025 financial results on Friday, May 9, 2025, prior to the market
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
GlobeNewswire Inc.
Mar 31, 2025 8:30 PM GMT
PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host a fireside chat at the 2025 RBC Capital Mark